Intersections of Fibrodysplasia Ossificans Progressiva and Traumatic Heterotopic Ossification

被引:9
|
作者
Juan, Conan [1 ]
Bancroft, Alec C. [1 ,2 ]
Choi, Ji Hae [1 ]
Nunez, Johanna H. [1 ]
Pagani, Chase A. [1 ]
Lin, Yen-Sheng [3 ]
Hsiao, Edward C. [4 ,5 ]
Levi, Benjamin [1 ]
机构
[1] Univ Texas Southwestern Med Ctr, Ctr Organogenesis Regenerat & Trauma, Dept Surg, Dallas, TX 75390 USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Univ Texas Southwestern Med Ctr, Dept Orthopaed Surg, Dallas, TX 75390 USA
[4] Univ Calif San Francisco, Inst Human Genet, Dept Med, Div Endocrinol & Metab,Med Ctr, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Program Craniofacial Biol, Med Ctr, San Francisco, CA 94143 USA
关键词
heterotopic ossification; fibrodysplasia ossificans progressiva; ectopic bone; ACVR2; ALK2; trauma; MESENCHYMAL STEM-CELLS; ECTOPIC BONE-FORMATION; TGF-BETA; OSTEOGENIC DIFFERENTIATION; TRANSCRIPTION FACTOR; MAMMALIAN TARGET; OSTEOBLASTIC DIFFERENTIATION; OSTEOCALCIN EXPRESSION; STEM/PROGENITOR CELLS; ALKALINE-PHOSPHATASE;
D O I
10.3390/biom14030349
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heterotopic ossification (HO) is a debilitating pathology where ectopic bone develops in areas of soft tissue. HO can develop as a consequence of traumatic insult or as a result of dysregulated osteogenic signaling, as in the case of the orphan disease fibrodysplasia ossificans progressiva (FOP). Traumatic HO (tHO) formation is mediated by the complex interplay of signaling between progenitor, inflammatory, and nerve cells, among others, making it a challenging process to understand. Research into the pathogenesis of genetically mediated HO (gHO) in FOP has established a pathway involving uninhibited activin-like kinase 2 receptor (ALK2) signaling that leads to downstream osteogenesis. Current methods of diagnosis and treatment lag behind pre-mature HO detection and progressive HO accumulation, resulting in irreversible decreases in range of motion and chronic pain for patients. As such, it is necessary to draw on advancements made in the study of tHO and gHO to better diagnose, comprehend, prevent, and treat both.
引用
收藏
页数:27
相关论文
共 50 条
  • [41] Fibrodysplasia ossificans progressiva
    Smit, Chane
    Uys, Andre
    CLINICAL CASE REPORTS, 2023, 11 (11):
  • [42] Fibrodysplasia ossificans progressiva
    Nucci, A
    Queiroz, LD
    Santos, AD
    Camargo, EE
    Moura-Ribeiro, MVL
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2000, 58 (2A) : 342 - 347
  • [43] Fibrodysplasia ossificans progressiva
    S. Mahboubi
    David L. Glaser
    Eileen M. Shore
    Frederick S. Kaplan
    Pediatric Radiology, 2001, 31 : 307 - 314
  • [44] FIBRODYSPLASIA OSSIFICANS PROGRESSIVA
    NEWTON, MC
    ALLEN, PW
    RYAN, DC
    BRITISH JOURNAL OF ANAESTHESIA, 1990, 64 (02) : 246 - 250
  • [45] FIBRODYSPLASIA OSSIFICANS PROGRESSIVA
    GROSS, S
    KATZNELSON, O
    GOODMAN, RM
    HAREFUAH, 1978, 95 (01) : 22 - 23
  • [46] Fibrodysplasia Ossificans Progressiva
    Rashid, Usman
    Bari, Attia
    Maqsood, Amna
    Naz, Samia
    Ahmad, Tahir Masood
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2016, 26 (02): : 154 - 155
  • [47] Fibrodysplasia Ossificans Progressiva
    Shaikh, Nadia
    Arif, Fehmina
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2011, 61 (04) : 397 - 399
  • [48] Fibrodysplasia ossificans progressiva
    Kumar, Rajiv Ranjan
    Dasgupta, Sauvik
    Suman, Shiv Kumar
    Kumar, Uma
    RHEUMATOLOGY, 2020, 59 (07) : 1789 - 1789
  • [49] Fibrodysplasia ossificans progressiva
    Zargar, AH
    Laway, BA
    Masoodi, SR
    Wani, AI
    Bashir, MI
    Wani, MM
    ANNALS OF SAUDI MEDICINE, 1999, 19 (06) : 525 - 526
  • [50] Fibrodysplasia ossificans progressiva
    Koss, T
    Garzon, MC
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 : 56 - 56